Considering the complicated role of the tumour microenvironment on development of drug resistance, the contribution of OPN in the animal’s internal environment and the clinical model settings, might be of little importance compared with what is predicted by studies performed in in vitro cell culture models. The gene discussed is SPP1; the disease is neoplasm.